RWA Wealth Partners LLC Acquires Shares of 22,011 Sociedad Quimica y Minera S.A. $SQM

RWA Wealth Partners LLC acquired a new stake in shares of Sociedad Quimica y Minera S.A. (NYSE:SQM) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 22,011 shares of the basic materials company’s stock, valued at approximately $776,000.

A number of other hedge funds also recently made changes to their positions in SQM. Kingstone Capital Partners Texas LLC bought a new position in Sociedad Quimica y Minera during the second quarter valued at approximately $67,759,000. Nuveen LLC purchased a new stake in shares of Sociedad Quimica y Minera during the 1st quarter worth approximately $39,154,000. RWC Asset Advisors US LLC purchased a new stake in shares of Sociedad Quimica y Minera during the 1st quarter worth approximately $37,170,000. Lord Abbett & CO. LLC bought a new position in shares of Sociedad Quimica y Minera during the 1st quarter valued at approximately $19,666,000. Finally, RWC Asset Management LLP bought a new position in shares of Sociedad Quimica y Minera during the 1st quarter valued at approximately $10,213,000. 12.41% of the stock is currently owned by hedge funds and other institutional investors.

Sociedad Quimica y Minera Trading Up 5.6%

Sociedad Quimica y Minera stock opened at $48.84 on Monday. The stock’s 50 day simple moving average is $44.33 and its two-hundred day simple moving average is $39.59. Sociedad Quimica y Minera S.A. has a 12 month low of $29.36 and a 12 month high of $49.58. The firm has a market cap of $13.95 billion, a PE ratio of 29.24 and a beta of 1.14. The company has a current ratio of 2.92, a quick ratio of 1.93 and a debt-to-equity ratio of 0.70.

Sociedad Quimica y Minera (NYSE:SQM) last issued its quarterly earnings data on Wednesday, August 20th. The basic materials company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.52 by ($0.21). The business had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.08 billion. Sociedad Quimica y Minera had a net margin of 11.29% and a return on equity of 9.09%. The firm’s revenue for the quarter was down 19.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.75 earnings per share. Analysts anticipate that Sociedad Quimica y Minera S.A. will post -1.31 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on SQM shares. JPMorgan Chase & Co. boosted their price target on shares of Sociedad Quimica y Minera from $39.00 to $41.00 and gave the stock a “neutral” rating in a research report on Monday, July 28th. Rothschild Redb upgraded shares of Sociedad Quimica y Minera to a “hold” rating in a report on Friday, October 24th. Itau BBA Securities began coverage on shares of Sociedad Quimica y Minera in a research report on Thursday, September 4th. They set an “outperform” rating and a $55.00 target price on the stock. Jefferies Financial Group reiterated a “hold” rating and issued a $50.00 price target (down previously from $53.00) on shares of Sociedad Quimica y Minera in a research report on Monday, October 6th. Finally, BMO Capital Markets boosted their price objective on Sociedad Quimica y Minera from $45.00 to $55.00 and gave the stock an “outperform” rating in a research note on Thursday, August 21st. Three analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $46.81.

Sociedad Quimica y Minera Profile

Sociedad Química y Minera de Chile SA operates as a mining company worldwide. The company offers specialty plant nutrients, including sodium potassium nitrate, specialty blends, and other specialty fertilizers under Ultrasol, Qrop, Speedfol, Allganic, Ultrasoline, ProP, and Prohydric brands. It also provides iodine and its derivatives for use in medical, agricultural, industrial, and human and animal nutrition products comprising x-ray contrast media, biocides, antiseptics and disinfectants, pharmaceutical intermediates, polarizing films for LCD and LED screens, chemicals, organic compounds, and pigments, as well as added to edible salt to prevent iodine deficiency disorders.